Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Senores Pharmaceuticals Ltd. (SENORES)
Market Closed
15 Oct, 10:00 AM
XNSE
All
(1)
IN
(1)
XNSE
Primary
₹
1,257.
10
-24.4
-1.904%
₹
52.02B
Market Cap
-
P/E Ratio
-
Div Yield
166,669
Volume
-
Eps
₹
1,281.5
Previous Close
Watching
Watch
Add Transaction
Day Range
1,254.1
1,297.4
Year Range
706
1,599
Want to track
SENORES
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Statistics
Historical Data
Senores Pharmaceuticals Ltd. (SENORES) Statistics
Valuation metrics
Market Cap
52.02B
Enterprise value
63.76B
Trailing P/E (ttm)
46.38
Forward P/E
24.26
PEG ratio
0.62
Price/Sales (ttm)
9.02
Price/Book (mrq)
6.51
Enterprise Value/Revenue
9.46
Enterprise Value/EBITDA
27.52
Overview
Shares outstanding
46.05M
Float
16.77M
Shares short
-
% Held by insiders
0.56%
% Held by institutions
0.08%
Average volume (10 days)
264.79K
Average volume (90 days)
241.68K
Price summary
52-Week low
706
52-Week high
1,599
Beta
-
50-Day moving average
1,420.9
200-Day moving average
1,221.74
Financials
Fiscal year
Fiscal year ends
31 Mar 2026
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.19%
Operating margin
0.25%
Operational effectiveness
Return on assets
0.08%
Return on equity
0.14%
Income Statement
Revenue (ttm)
6.8B
Revenue per share (ttm)
146.27
Quarterly revenue growth (yoy)
0.69%
Gross profit (ttm)
4.28B
EBITDA
1.8B
Net income to common (ttm)
1.16B
Diluted EPS (ttm)
27.44
Quarterly earnings growth (yoy)
0.77%
Balance Sheet
Total cash (mrq)
1.6B
Total cash per share (mrq)
34.66
Total debt (mrq)
3.42B
Total Debt/Equity (mrq)
0.37
Current ratio (mrq)
1.92%
Book value per share (mrq)
209.44
Cash Flow
Cash flow statement
620.5M
Levered free cash flow (LFCF)
-2.57B